Publications by authors named "Nicola Heyer"
Background: The association between obesity and disease severity in COVID-19 has been reported, whilst the impact of undernutrition remains less well-defined. Here we describe nutritional risk profiles of consecutive COVID-19 hospital inpatients, together with clinical outcomes and the impact of nutritional therapy.
Methods: This was a retrospective case-control study of adult inpatients admitted to University College London Hospital between February and July 2020 with PCR-confirmed SARS-CoV-2.
Article Synopsis
- The study aimed to analyze and compare the drug-survival rates of adalimumab and etanercept (including their biosimilars) in patients with Enthesitis-Related Arthritis (ERA) who had never received biologic treatment before.* -
- In total, 188 patients were observed over a period where 99 discontinued treatment, revealing a median survival time of 3.9 years, with adalimumab showing significantly longer survival rates than etanercept (4.9 years vs 2 years).* -
- Factors such as the combination of adalimumab with methotrexate, the presence of HLA-B27, and baseline CRP levels influenced drug-survival, with axial-ERA